Institution
University of Erlangen-Nuremberg
Education•Erlangen, Bayern, Germany•
About: University of Erlangen-Nuremberg is a education organization based out in Erlangen, Bayern, Germany. It is known for research contribution in the topics: Population & Immune system. The organization has 42405 authors who have published 85600 publications receiving 2663922 citations.
Topics: Population, Immune system, Breast cancer, Catalysis, Transplantation
Papers published on a yearly basis
Papers
More filters
••
University of British Columbia1, University of Calgary2, Harvard University3, Johns Hopkins University4, International Society of Nephrology5, Veterans Health Administration6, Merck & Co.7, University of Groningen8, Concord Repatriation General Hospital9, University of Freiburg10, University of Michigan11, Tufts University12, University of Zurich13, University of California, San Diego14, Panamerican University15, University of Alberta16, University of Sydney17, Karolinska Institutet18, University of Washington19, University College London20, University of Erlangen-Nuremberg21
TL;DR: An action plan and performance framework based on ten themes to strengthen CKD surveillance, tackle major risk factors for CKD, and enhance understanding of the genetic causes of CKD is presented.
624 citations
••
Medical Research Council1, National Institute for Health Research2, King's College London3, University of Cambridge4, Trinity College, Dublin5, University of Nottingham6, Queen's University Belfast7, University of Southampton8, University of Manchester9, John Radcliffe Hospital10, University of Bristol11, UCL Institute of Neurology12, University of Bonn13, University of Hamburg14, University of Erlangen-Nuremberg15, University of Duisburg-Essen16, Ludwig Maximilian University of Munich17, Heidelberg University18, University College Dublin19, University of Freiburg20, Washington University in St. Louis21, Brigham Young University22, Wellcome Trust Sanger Institute23, National Institutes of Health24, University of Göttingen25, Mayo Clinic26
TL;DR: Independent evidence from two large studies demonstrates that these processes related to cholesterol metabolism and the innate immune response are aetiologically relevant, and suggests that they may be suitable targets for novel and existing therapeutic approaches.
Abstract: Background
1Late Onset Alzheimer's disease (LOAD) is the leading cause of dementia. Recent large genome-wide association studies (GWAS) identified the first strongly supported LOAD susceptibility genes since the discovery of the involvement of APOE in the early 1990s. We have now exploited these GWAS datasets to uncover key LOAD pathophysiological processes.
Methodology
We applied a recently developed tool for mining GWAS data for biologically meaningful information to a LOAD GWAS dataset. The principal findings were then tested in an independent GWAS dataset.
Principal Findings
We found a significant overrepresentation of association signals in pathways related to cholesterol metabolism and the immune response in both of the two largest genome-wide association studies for LOAD.
Significance
Processes related to cholesterol metabolism and the innate immune response have previously been implicated by pathological and epidemiological studies of Alzheimer's disease, but it has been unclear whether those findings reflected primary aetiological events or consequences of the disease process. Our independent evidence from two large studies now demonstrates that these processes are aetiologically relevant, and suggests that they may be suitable targets for novel and existing therapeutic approaches.
624 citations
••
University of Copenhagen1, École Polytechnique Fédérale de Lausanne2, University of Michigan3, Ramon Llull University4, Purdue University5, European School of Management and Technology6, Aarhus University7, University of Surrey8, Royal Holloway, University of London9, Maastricht University10, Johannes Kepler University of Linz11, Copenhagen Business School12, Royal Institute of Technology13, University of Southern California14, Simon Fraser University15, University of Erlangen-Nuremberg16, University of Wisconsin–Milwaukee17, RWTH Aachen University18, University of Southern Denmark19, Polytechnic University of Milan20, Babson College21, Imperial College London22
TL;DR: In this article, the authors present opportunities for future research on OI, organized at different levels of analysis, and discuss some of the contingencies at these different levels, and argue that future research needs to study OI - originally an organisational-level phenomenon.
Abstract: This paper provides an overview of the main perspectives and themes emerging in research on open innovation (OI). The paper is the result of a collaborative process among several OI scholars – having a common basis in the recurrent Professional Development Workshop on ‘Researching Open Innovation’ at the Annual Meeting of the Academy of Management. In this paper, we present opportunities for future research on OI, organised at different levels of analysis. We discuss some of the contingencies at these different levels, and argue that future research needs to study OI – originally an organisational-level phenomenon – across multiple levels of analysis. While our integrative framework allows comparing, contrasting and integrating various perspectives at different levels of analysis, further theorising will be needed to advance OI research. On this basis, we propose some new research categories as well as questions for future research – particularly those that span across research domains that have so far developed in isolation.
623 citations
••
TL;DR: This paper created a challenging real-world copy-move dataset, and a software framework for systematic image manipulation, and examined the 15 most prominent feature sets, finding the keypoint-based features Sift and Surf as well as the block-based DCT, DWT, KPCA, PCA, and Zernike features perform very well.
Abstract: A copy-move forgery is created by copying and pasting content within the same image, and potentially postprocessing it. In recent years, the detection of copy-move forgeries has become one of the most actively researched topics in blind image forensics. A considerable number of different algorithms have been proposed focusing on different types of postprocessed copies. In this paper, we aim to answer which copy-move forgery detection algorithms and processing steps (e.g., matching, filtering, outlier detection, affine transformation estimation) perform best in various postprocessing scenarios. The focus of our analysis is to evaluate the performance of previously proposed feature sets. We achieve this by casting existing algorithms in a common pipeline. In this paper, we examined the 15 most prominent feature sets. We analyzed the detection performance on a per-image basis and on a per-pixel basis. We created a challenging real-world copy-move dataset, and a software framework for systematic image manipulation. Experiments show, that the keypoint-based features Sift and Surf, as well as the block-based DCT, DWT, KPCA, PCA, and Zernike features perform very well. These feature sets exhibit the best robustness against various noise sources and downsampling, while reliably identifying the copied regions.
623 citations
••
TL;DR: Ribociclib plus fulvestrant might represent a new first- or second-line treatment option in hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer.
Abstract: PurposeThis phase III study evaluated ribociclib plus fulvestrant in patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer who were treatment naive or had received up to one line of prior endocrine therapy in the advanced setting.Patients and MethodsPatients were randomly assigned at a two-to-one ratio to ribociclib plus fulvestrant or placebo plus fulvestrant. The primary end point was locally assessed progression-free survival. Secondary end points included overall survival, overall response rate, and safety.ResultsA total of 484 postmenopausal women were randomly assigned to ribociclib plus fulvestrant, and 242 were assigned to placebo plus fulvestrant. Median progression-free survival was significantly improved with ribociclib plus fulvestrant versus placebo plus fulvestrant: 20.5 months (95% CI, 18.5 to 23.5 months) versus 12.8 months (95% CI, 10.9 to 16.3 months), respectively (hazard ratio, 0.593; 95% CI, 0.480 to 0.732; P < .001). Consiste...
622 citations
Authors
Showing all 42831 results
Name | H-index | Papers | Citations |
---|---|---|---|
Hermann Brenner | 151 | 1765 | 145655 |
Richard B. Devereux | 144 | 962 | 116403 |
Manfred Paulini | 141 | 1791 | 110930 |
Daniel S. Berman | 141 | 1363 | 86136 |
Peter Lang | 140 | 1136 | 98592 |
Joseph Sodroski | 138 | 542 | 77070 |
Richard J. Johnson | 137 | 880 | 72201 |
Jun Lu | 135 | 1526 | 99767 |
Michael Schmitt | 134 | 2007 | 114667 |
Jost B. Jonas | 132 | 1158 | 166510 |
Andreas Mussgiller | 127 | 1059 | 73778 |
Matthew J. Budoff | 125 | 1449 | 68115 |
Stefan Funk | 125 | 506 | 56955 |
Markus F. Neurath | 124 | 934 | 62376 |
Jean-Marie Lehn | 123 | 1054 | 84616 |